UnknownNot Applicable

Non-invasive Left-sided Cervical Vagus Nerve Stimulation for Atrioventricular Reentrant Tachycardia

China10 participantsStarted 2023-01-10

Plain-language summary

The goal of this Interventional clinical trials in atrioventricular reentrant tachycardia patients. The main question it aims to answer whether non-invasive vagus nerve stimulation could be effective in restoring rhythm. Patients will receive non-invasive vagus nerve electrical stimulation under catheter evoked and cardiac monitoring to observe their heart rhythm changes.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Supraventricular Tachycardia (svt) need to be met.
✓. All need to be free of psychiatric abnormalities, verbal communication disorders, and have good compliance.
✓. The patients and their families gave informed consent and signed the informed consent form.

Exclusion criteria

✕. Does not meet the relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Supraventricular Tachycardia (svt).
✕. Mental anomalies, verbal communication disorders, poor adherence
✕. Those who do not consent to participate in this clinical trial

What they're measuring

Whether the tachycardia is repetitive or not

Timeframe: 10minutes

Trial details

NCT IDNCT06219343

SponsorJingye Tai

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-10

Contact for this trial

Ai-lan Chen

13719198832 1228327958@qq.com

View on ClinicalTrials.gov More Atrioventricular Reentrant Tachycardia trials